Skip to content
akaturk Academic measurement

Academician profile · PROFESÖR

BİRCAN KAYAASLAN

ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
  • TIP FAKÜLTESİ
  • DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Articles YÖKSİS 100
Projects 1
Books 10
Proceedings 163
Patents 1
Artistic 1
Scopus (SJR)
Q1 30 Q2 14 Q3 15 Q4 12
WoS (JCR)
Q1 19 Q2 13 Q3 12 Q4 32
TR Index 22 articles

Scopus (SJR)

WoS (JCR)

TR Index

22 articles

100 publications total

Articles

  1. 2023 Development and validation of COVID-19 associated candidemia score (CAC-Score) in ICU patients Mycoses DOI 10.1111/myc.13531.
  2. 2023 PROSPECTIVE ANALYSIS OF FEBRILE NEUTROPENIA PATIENTS WITH BACTERAEMIA: THE RESULTS OF AN INTERNATIONAL ID-IRI STUDY International journal of antimicrobial agents. DOI 10.1016/j.ijantimicag.2023.106919
  3. 2023 Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study Eur J Clin Microbiol Infect Dis DOI 10.1007/s10096-023-04561-5
  4. 2023 Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) International Journal of Antimicrobial Agents DOI 10.1016/j.ijantimicag.2023.106734
  5. 2023 BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses Among Transplant Recipients Who Had Received Two Doses of CoronaVac Viruses
  6. 2023 BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses Among Transplant Recipients Who Had Received Two Doses of CoronaVac Viruses DOI 10.1007/s00134-022-06944-2
  7. 2023 COVID-19: booster(s) vs. hospitalization and Intensive Care Unit admission European Review for Medical and Pharmacological Sciences DOI 10.26355/eurrev_202303_31586
  8. 2023 Investigation of SARS-CoV-2 using RT-PCR in vaginal swab samples of female patients with a diagnosis of severe COVID-19 Taiwan J Obstet Gynecol DOI 10.1016/j.tjog.2022.11.007
  9. 2023 Effect of 2 Different High-Dose Methylprednisolone Treatments on Clinical Outcomes in Severe COVID-19 Patients Turkish Thoracic Journal DOI 10.5152/ThoracResPract.2023.22050
  10. 2022 Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients Frontiers in Medicine DOI 10.3389/fmed.2022.957598
  11. 2022 Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results European Journal of Clinical Microbiology & Infectious Diseases DOI 10.1007/s10096-021-04392-2
  12. 2022 Investigation of the relation between risk assessment of exposure and nosocomial SARS-CoV-2 transmission in healthcare workers: a prospective single-centre study BMJ Open DOI 10.1136/bmjopen-2021-056858
  13. 2022 Response to the letter to the editor Journal of Infection and Public Health DOI 10.1016/j.jiph.2021.12.007
  14. 2022 Incidence and risk factors for COVID-19 associated candidemia (CAC) in ICU patients MYCOSES DOI 10.1111/myc.13431
  15. 2022 COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity Endocrine DOI 10.1007/s12020-022-03140-6
  16. 2022 Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial Vaccines DOI 10.3390/vaccines10111865
  17. 2022 Incidence and risk factors for COVID-19 associated candidemia (CAC) in ICU patients MYCOSES DOI 10.1111/myc.13431
  18. 2022 Response to the letter to the editor Journal of Infection and Public Health DOI 10.1016/j.jiph.2021.12.007
  19. 2022 Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial Vaccines DOI 10.3390/vaccines10111865
  20. 2022 Sarcopenia and Its Prognostic Role on Hospitalization and In-Hospital Mortality in Coronavirus Disease 2019 Patients with At Least One Cardiovascular Risk Factor Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology DOI 10.5543/tkda.2022.21167

Back to academicians